The 2025 Autism Science Foundation review highlights exciting progress in understanding autism's biological diversity and subtypes, despite some research disruptions. Recent studies show promise in early screening tools, like a tablet-based behavioral analysis system supported by NIMH. Evidence-based treatments, such as risperidone for certain symptoms, continue to be validated (CHOP research). Always verify therapies through scientific sources—personal anecdotes aren't enough (NorthShore). For comprehensive updates, check the CDC's treatment guidelines or Autism Research Institute's clinician resources. Stay hopeful; science is making strides!

(Key sources: [2][3][6][7][8])